ライフサイエンスコーパス: Newcastle disease virus

1 ells infected with a heterologous RNA virus (Newcastle disease virus).

2 ing a control or fusion protein derived from Newcastle disease virus.

3 idase (HN) glycoprotein of the paramyxovirus Newcastle disease virus.

4 onse to HSV-1, but not to Sendai virus or to Newcastle disease virus.

5 d to rescue replication of the IFN-sensitive Newcastle disease virus.

6 nts similar to the one for cells infected by Newcastle disease virus.

7 omography to show that the matrix protein of Newcastle disease virus, a paramyxovirus and relative of

8 mutation is demonstrated in the F protein of Newcastle disease virus, a paramyxovirus of a different

9 nduced by all IL-33-inducing agonists except Newcastle disease virus, a RIG-I agonist that induced ex

10 We found that matrix proteins purified from Newcastle disease virus adsorb on a phospholipid bilayer

11 d RNA viruses that have dsRNA intermediates, Newcastle disease virus and Sendai virus, and a DNA viru

12 Newcastle disease virus and vesicular stomatitis virus (

13 In this study, we found Newcastle disease virus and vesicular stomatitis virus r

14 from non-target viruses such as H6N2, H9N2, Newcastle disease virus, and infectious bronchitis virus

15 efficacy: vaccinia, measles, mumps, viruses, Newcastle disease virus, and reovirus.

16 ense RNA viruses (influenza viruses A and B, Newcastle disease virus, and vesicular stomatitis virus)

17 simplex virus type-1 (HSV-1), Sendai virus, Newcastle disease virus, and vesicular stomatitis virus.

18 W proteins) were expressed from recombinant Newcastle disease viruses, and the responses of infected

19 Newcastle disease virus assembles in plasma membrane dom

20 PV701, a replication-competent strain of Newcastle disease virus, causes regression of tumor xeno

21 packaging revealed a majority of infectious Newcastle disease viruses contain one functional genome.

22 Here, we present a recombinant Newcastle disease virus expressing a North American line

23 ns for the ability to rescue the growth of a Newcastle disease virus expressing green fluorescent pro

24 mutational analysis of the HR1 domain of the Newcastle disease virus fusion protein, focusing on the

25 This model uses the Newcastle disease virus hemagglutinin-neuraminidase prot

26 on of HN of parainfluenza virus 5 (PIV5) and Newcastle disease virus HN abolishes cell-cell fusion, w

27 Here, we report the structure of the Newcastle disease virus HN ectodomain, revealing dimers

28 embrane fusion, we characterized a series of Newcastle disease virus HN proteins whose surface residu

29 ith functionally active "headless" mumps and Newcastle disease virus HN proteins, provide insights in

30 Mutations of the Newcastle disease virus HN stalk region have been shown

31 ose to the second binding site identified in Newcastle disease virus HN.

32 e second receptor-binding site identified in Newcastle disease virus HN.

33 paramyxoviruses measles virus, mumps virus, Newcastle disease virus, human parainfluenza virus 3, an

34 d receptor binding site of the paramyxovirus Newcastle disease virus in its function and its relation

35 the growth of a highly IFN-sensitive virus (Newcastle disease virus) in the presence of IFN, suggest

36 nd tumor necrosis factor alpha (TNFalpha) in Newcastle disease virus-infected Irf5(-)(/)(-) mice.

37 not type I interferon gene transcription in Newcastle disease virus-infected peritoneal macrophages.

38 Quantitative RT-PCR analysis on Newcastle disease virus-infected primary DCs from 130 in

39 le NF-kappaB activity, both Sendai virus and Newcastle disease virus infection led to robust IFN-beta

40 N expression in response to Sendai virus and Newcastle disease virus infection.

41 ther stimuli, such as lipopolysaccharide and Newcastle disease virus infection.

42 on of interferon beta mRNA 27-fold following Newcastle disease virus infection.

43 As with any other RNA virus, Newcastle disease virus is expected to evolve naturally;

44 opathological characterization of a virulent Newcastle disease virus isolate (NDV-Peru/08) obtained f

45 Newcastle disease viruses isolated from Hong Kong live b

46 ed to mimic sites that are found in virulent Newcastle disease virus isolates and to contain 4 or 5 b

47 Eight Newcastle disease virus isolates from Pakistan were sequ

48 Fifteen Newcastle disease virus isolates were recovered only fro

49 DCs) by negative-strand RNA viruses, such as Newcastle disease virus, leads to the induction of the I

50 Low-virulence Newcastle disease viruses (loNDV) are frequently recover

51 hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus mediates attachment to sialic ac

52 the response of DCs to virus infection with Newcastle disease virus (NDV) after a 24-hour E2 treatme

53 VLP is composed of the NP and M proteins of Newcastle disease virus (NDV) and a chimeric protein con

54 MuRantes mRNA expression is induced by Newcastle disease virus (NDV) and LPS in the RAW 264.7 m

55 The fusion (F) proteins of Newcastle disease virus (NDV) and Nipah virus (NiV) are

56 he level of IFN-beta protein induced by both Newcastle disease virus (NDV) and Sendai virus infection

57 In this study, we have evaluated Newcastle disease virus (NDV) as a vaccine vector for no

58 c and mucosal immune responses by the use of Newcastle disease virus (NDV) as a vaccine vector.

59 linical development of a mesogenic strain of Newcastle disease virus (NDV) as an oncolytic agent for

60 Newcastle disease virus (NDV) belongs to serotype 1 of t

61 Newcastle disease virus (NDV) can cause severe disease i

62 Virulent strains of Newcastle disease virus (NDV) cause Newcastle disease (N

63 Virus-like particles (VLPs) built on the Newcastle disease virus (NDV) core proteins, NP and M, a

64 h virus-like particles (VLPs) containing the Newcastle disease virus (NDV) core proteins, NP and M, a

65 several paramyxoviruses.IMPORTANCE Oncolytic Newcastle disease virus (NDV) could establish persistent

66 Newcastle disease virus (NDV) edits its P gene by insert

67 Newcastle disease virus (NDV) entry into host cells is m

68 Newcastle disease virus (NDV) expressing HIV-1 BaL gp160

69 respiratory tract based on recombinant avian Newcastle disease virus (NDV) expressing the hemagglutin

70 such a stimulus, we generated a recombinant Newcastle disease virus (NDV) expressing the MV hemagglu

71 iotin-labeled peptides with sequences of the Newcastle disease virus (NDV) F protein heptad repeat 2

72 and 289 in the structure and function of the Newcastle disease virus (NDV) F protein was explored by

73 the basis of the coordinates of the related Newcastle disease virus (NDV) F protein, Valine-94, a de

74 ith those of the parainfluenza virus SV5 and Newcastle disease virus (NDV) F proteins, the structures

75 has been demonstrated that the V protein of Newcastle disease virus (NDV) functions as an alpha/beta

76 The effects of Newcastle disease virus (NDV) fusion (F) glycoprotein cl

77 The sequence and structure of the Newcastle disease virus (NDV) fusion (F) protein are con

78 Newcastle disease virus (NDV) fusion (F) protein directs

79 It has been shown that the L289A-mutated Newcastle disease virus (NDV) fusion (F) protein gains t

80 The synthesis of the Newcastle disease virus (NDV) fusion (F) protein in a ce

81 equences in the transmembrane (TM) domain of Newcastle disease virus (NDV) fusion (F) protein in the

82 The role of N-linked glycosylation of the Newcastle disease virus (NDV) fusion (F) protein in vira

83 To explore the association of the Newcastle disease virus (NDV) fusion (F) protein with ch

84 The Newcastle disease virus (NDV) fusion protein (F) mediate

85 y viral fusion proteins, the sequence of the Newcastle disease virus (NDV) fusion protein has several

86 Naturally occurring strains of Newcastle disease virus (NDV) have shown oncolytic thera

87 The Newcastle disease virus (NDV) hemagglutinin-neuraminidas

88 onstrate that the F-interactive sites on the Newcastle disease virus (NDV) hemagglutinin-neuraminidas

89 To explore the relationships between Newcastle disease virus (NDV) HN and F protein interacti

90 Newcastle disease virus (NDV) HN and HPIV3 HN respond di

91 The stalk region of the Newcastle disease virus (NDV) HN protein has been implic

92 alysis of the three-dimensional structure of Newcastle disease virus (NDV) HN protein revealed the pr

93 e residues in the functional activity of the Newcastle disease virus (NDV) HN protein.

94 tion, mutations in a conserved domain in the Newcastle disease virus (NDV) HN stalk result in a sharp

95 porated into progeny Sendai virions, whereas Newcastle disease virus (NDV) HN was not.

96 e second receptor-binding site identified in Newcastle disease virus (NDV) HN.

97 morbidity-mortality event involving virulent Newcastle disease virus (NDV) in wild double-crested cor

98 Upon newcastle disease virus (NDV) infection, bone marrow-der

99 We show that, in addition to Newcastle disease virus (NDV) infection, vesicular stoma

100 hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV) is a multifunctional prote

101 Newcastle disease virus (NDV) is a negative-sense RNA vi

102 Newcastle disease virus (NDV) is a negative-strand RNA v

103 hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV) is an important determinan

104 Newcastle disease virus (NDV) is an oncolytic virus bein

105 The characteristics of three virulent Newcastle disease virus (NDV) isolates from this outbrea

106 However, VLPs composed of the Newcastle disease virus (NDV) nucleocapsid and membrane

107 The disease is caused by Newcastle disease virus (NDV) or avian paramyxovirus typ

108 A Newcastle disease virus (NDV) outbreak in chickens was r

109 hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV) plays a crucial role in th

110 We generated a recombinant Newcastle disease virus (NDV) possessing a two-segmented

111 In the present study, we generated Newcastle disease virus (NDV) recombinants expressing gl

112 In the present study, we generated Newcastle disease virus (NDV) recombinants, based on the

113 tinin-neuraminidase (HN) cytoplasmic tail in Newcastle disease virus (NDV) replication and pathogenic

114 The promotion of membrane fusion by Newcastle disease virus (NDV) requires an interaction be

115 Ps) released from avian cells expressing the Newcastle disease virus (NDV) strain AV proteins NP, M,

116 The complete genome sequence of an African Newcastle disease virus (NDV) strain isolated from a chi

117 Newcastle disease virus (NDV) strains are classified as

118 onomic losses, but little is known about the Newcastle disease virus (NDV) strains circulating in Afr

119 Naturally occurring Newcastle disease virus (NDV) strains vary greatly in vi

120 Naturally occurring Newcastle disease virus (NDV) strains vary greatly in vi

121 Eight highly virulent Newcastle disease virus (NDV) strains were isolated from

122 ystallographic structure of an HN dimer from Newcastle disease virus (NDV) suggests that a single sit

123 We have generated a recombinant Newcastle disease virus (NDV) that expresses the green f

124 A complete cDNA clone of the Newcastle disease virus (NDV) vaccine strain Hitchner B1

125 Thermostable Newcastle disease virus (NDV) vaccines have been used wi

126 he present study, we generated a recombinant Newcastle disease virus (NDV) vectoring the fusion (F) p

127 Newcastle disease virus (NDV) was isolated from an outbr

128 the membrane cytoskeleton in the assembly of Newcastle disease virus (NDV) were investigated.

129 ression of the fusion glycoprotein of RSV by Newcastle disease virus (NDV) would stimulate a more rob

130 xpression, replication, and pathogenicity of Newcastle disease virus (NDV), a green fluorescent prote

131 Newcastle disease virus (NDV), a member of the family Pa

132 Pteropus vampyrus bat kidney (PVK) cells to Newcastle disease virus (NDV), an avian paramyxovirus kn

133 We evaluated Newcastle disease virus (NDV), an avian paramyxovirus th

134 To address this issue, we evaluated Newcastle disease virus (NDV), an avian paramyxovirus th

135 We previously engineered Newcastle disease virus (NDV), an avian paramyxovirus, a

136 Newcastle disease virus (NDV), an avian paramyxovirus, i

137 Newcastle disease virus (NDV), an avian paramyxovirus, i

138 Newcastle disease virus (NDV), an avian paramyxovirus, i

139 Newcastle disease virus (NDV), an avian paramyxovirus, i

140 Newcastle disease virus (NDV), an avian paramyxovirus, i

141 the F proteins of SV5 (W3A and WR isolates), Newcastle disease virus (NDV), and human parainfluenza v

142 cular stomatitis virus (VSV), Sindbis virus, Newcastle disease virus (NDV), and Sendai virus (SeV), w

143 of the H5 and H7 hemagglutinin subtypes, and Newcastle disease virus (NDV), are important pathogens i

144 Paramyxoviruses, such as Newcastle disease virus (NDV), assemble in and bud from

145 es such as avian metapneumovirus (aMPV), and Newcastle disease virus (NDV), human pathogens such as h

146 Here we find that intratumoral therapy with Newcastle disease virus (NDV), in addition to the activa

147 yxovirus 1 (APMV-1) RNA, also referred to as Newcastle disease virus (NDV), in clinical samples from

148 When infected with Newcastle Disease Virus (NDV), NOD2 expression in DCs wa

149 For Newcastle disease virus (NDV), one bifunctional site (si

150 Virulent and moderately virulent strains of Newcastle disease virus (NDV), representing avian paramy

151 DCs showed a reduced type I IFN response to Newcastle disease virus (NDV), Sendai virus (SeV), and S

152 For many paramyxoviruses, including Newcastle disease virus (NDV), syncytium formation requi

153 ns (UTRs) in replication and pathogenesis of Newcastle disease virus (NDV), we generated recombinant

154 is hypothesis, L929 cells were infected with Newcastle disease virus (NDV), which led to the inductio

155 Cells infected with a Newcastle disease virus (NDV)-expressing VP35 redistribu

156 Newcastle disease virus (NDV)-induced membrane fusion re

157 Newcastle disease virus (NDV)-induced membrane fusion re

158 e effects of lipopolysaccharide (LPS) on the Newcastle disease virus (NDV)-mediated induction of cyto

159 In this study, we show that Newcastle disease virus (NDV)-vectored H7 (NDV-H7) and N

160 r IRF phosphorylation in cells infected with Newcastle disease virus (NDV).

161 e of preexisting immunity in humans, such as Newcastle disease virus (NDV).

162 Newcastle disease virus [NDV (avian paramyxovirus type 1

163 modulate fusion (numbering according to the Newcastle disease virus [NDV] F protein sequence).

164 ession after infection with either Sendai or Newcastle disease viruses or after engagement of the Tol

165 r ordered assembly and release of infectious Newcastle disease virus particles.

166 ion with vectored vaccine, using recombinant Newcastle disease virus (rNDV) expressing glycoprotein D

167 A recombinant Newcastle disease virus (rNDV) expressing simian immunod

168 Recombinant Newcastle disease virus (rNDV) stands out as a vaccine v

169 me this obstacle, we generated a recombinant Newcastle disease virus (rNDV)-vectored experimental nor

170 Using reverse genetics, three recombinant Newcastle disease viruses (rNDVs) were engineered, each

171 ed against CPE resulting from infection with Newcastle disease virus, Sendai virus, canine distemper

172 or Streptococcus, but not Vibrio cholerae or Newcastle disease virus sialidase.

173 Overexpression of Lgp2 inhibits SV and Newcastle disease virus signaling to IFN-stimulated regu

174 We report here that for Newcastle disease virus, the HN receptor avidity is incr

175 rs by about 2.5-fold, and neuraminidase from Newcastle disease virus typically increased infectivity

176 Isolates from the 2002-2003 virulent Newcastle disease virus (v-NDV) outbreak in southern Cal

177 One year after a virulent Newcastle disease virus (vNDV) outbreak in Pakistan, the

178 aramyxovirus 1 (APMV-1; a group encompassing Newcastle disease virus), which is a highly contagious p

179 y this network, we studied DCs infected with Newcastle disease virus, which is able to stimulate inna

180 in primary human dendritic cells infected by Newcastle disease virus, with copy numbers varying from

181 Using recombinant influenza and Newcastle disease viruses, with or without the NS1 gene